Our Vision
 at the peri-infarct zone 3 days post myocardial infarction The potential involvement of the TRPV2 Ca2+channel in cardiac pathology, oncology and cardiac-oncology. A TRPV2 blocking agent is being developed in collaboration with the BLAVATNIK center for drug discovery.  are highly involved in mediating cardiac pathology and progression to reno-cardiac syndrome following cardiac injury Highlighted Publications
Translational-oriented research of cardiac pathology Our Team
            
                                    
                                
                                
                                    
                                
                                
                                    
                                
                                 Research
            
                                    
                                
                                
                                    
                                
                                
